Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oscient Pharmaceuticals Corp
Original Assignee
Collaborative Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/470,911external-prioritypatent/US4661454A/en
Application filed by Collaborative Research IncfiledCriticalCollaborative Research Inc
Priority to CA000524168ApriorityCriticalpatent/CA1273883A/fr
Application grantedgrantedCritical
Publication of CA1273883ApublicationCriticalpatent/CA1273883A/fr
Process for marking hepatitis b s and pres2 proteines in pichia yeasts, the vectors for them and process for producing pichia stocks transformed with them
Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form